An activist investor has reshaped the board, securing the departures of STAAR’s CEO and chair.
STAAR CEO and chair exit as Broadwood reshapes board after rejecting Alcon buyout
Broadwood Capital, after taking a 31% stake in STAAR, led a proxy battle that ended with STAAR shareholders rejecting Alcon’s buyout offer. In a cooperation agreement that could pay Broadwood up to $6 million, STAAR agreed to expand its board and accept the resignations of its CEO and chair, while Broadwood agreed not to pursue…
Activist Investment activist investor activist-investing Alcon Alcon bid Alcon buyout board changes board governance Board reshuffle Board seats board shakeup board-change board-restructure Boardroom Battle Boston Scientific Broadwood Capital BTIG CEO departure CEO resignation CEO-search China market Chinese market Chinese ophthalmic market cooperation agreement corporate-governance ethylene oxide healthcare-investing Johnson & Johnson M&A MedTech Medtronic Mergers & Acquisitions Mergers and acquisitions ophthalmic ophthalmic devices ophthalmology proxy battle proxy fight ReCor Medical regulation STAAR STAAR Surgical standalone-strategy Yunqi Capital